Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Young patients with alopecia areata are satisfied with Janus kinase inhibitors, noting hair regrowth and improved quality of life.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Baricitinib is effective and safe for treating severe alopecia areata.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Guidelines help design better trials to compare alopecia areata treatments.

Hair thickness differences help diagnose hair loss severity.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Pix Liquida may help treat alopecia areata.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

The BASP classification helps predict patient behavior and improve treatment for hair loss.

New scale reliably assesses male hair loss with female pattern.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

EfficientNet improves accuracy in diagnosing hair loss stages.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Hair loss common in Norwegian men, affecting self-esteem and life quality.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

The new visual scale is a quick and effective way to measure hair loss in women.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

Stress significantly contributes to hair loss, especially in women and those aged 31-40.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.